Eli Lilly (LLY)
(Delayed Data from NYSE)
$734.97 USD
-20.94 (-2.77%)
Updated May 3, 2024 04:00 PM ET
After-Market: $735.54 +0.57 (0.08%) 7:58 PM ET
3-Hold of 5 3
D Value F Growth A Momentum D VGM
Brokerage Reports
Eli Lilly and Company [LLY]
Reports for Purchase
Showing records 121 - 140 ( 426 total )
Company: Eli Lilly and Company
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: Eli Lilly and Company
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: Eli Lilly and Company
Industry: Large Cap Pharmaceuticals
Comprehensive Technical and Fundamental Analysis for LLY.
Provider: Stock Traders Daily
Analyst: Research Department
Company: Eli Lilly and Company
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: Eli Lilly and Company
Industry: Large Cap Pharmaceuticals
Comprehensive Technical and Fundamental Analysis for LLY.
Provider: Stock Traders Daily
Analyst: Research Department
Company: Eli Lilly and Company
Industry: Large Cap Pharmaceuticals
Comprehensive Technical and Fundamental Analysis for LLY.
Provider: Stock Traders Daily
Analyst: Research Department
Company: Eli Lilly and Company
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: Eli Lilly and Company
Industry: Large Cap Pharmaceuticals
Comprehensive Technical and Fundamental Analysis for LLY.
Provider: Stock Traders Daily
Analyst: Research Department
Company: Eli Lilly and Company
Industry: Large Cap Pharmaceuticals
Comprehensive Technical and Fundamental Analysis for LLY.
Provider: Stock Traders Daily
Analyst: Research Department
Company: Eli Lilly and Company
Industry: Large Cap Pharmaceuticals
Comprehensive Technical and Fundamental Analysis for LLY.
Provider: Stock Traders Daily
Analyst: Research Department
Company: Eli Lilly and Company
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: Eli Lilly and Company
Industry: Large Cap Pharmaceuticals
Comprehensive Technical and Fundamental Analysis for LLY.
Provider: Stock Traders Daily
Analyst: Research Department
Company: Eli Lilly and Company
Industry: Large Cap Pharmaceuticals
Comprehensive Technical and Fundamental Analysis for LLY.
Provider: Stock Traders Daily
Analyst: Research Department
Company: Eli Lilly and Company
Industry: Large Cap Pharmaceuticals
Comprehensive Technical and Fundamental Analysis for LLY.
Provider: Stock Traders Daily
Analyst: Research Department
Company: Eli Lilly and Company
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: Eli Lilly and Company
Industry: Large Cap Pharmaceuticals
Comprehensive Technical and Fundamental Analysis for LLY.
Provider: Stock Traders Daily
Analyst: Research Department
Company: Eli Lilly and Company
Industry: Large Cap Pharmaceuticals
Comprehensive Technical and Fundamental Analysis for LLY.
Provider: Stock Traders Daily
Analyst: Research Department
Company: Eli Lilly and Company
Industry: Large Cap Pharmaceuticals
Key Takeaways From COVID-19 Vaccines and Antivirals Panels at Life Sciences Conference
Provider: H.C. Wainwright & Co., Inc.
Analyst: TRUCCHIO P
Company: Eli Lilly and Company
Industry: Large Cap Pharmaceuticals
Comprehensive Technical and Fundamental Analysis for LLY.
Provider: Stock Traders Daily
Analyst: Research Department
Company: Eli Lilly and Company
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department